13 results on '"Michelle Hou"'
Search Results
2. Marer, Michelle Hou
- Author
-
Marer, Michelle Hou and Marer, Michelle Hou
- Published
- 2024
3. Rescuing the right ventricle: A conceptual framework to target new interventions for patients receiving a durable left ventricular assist device
- Author
-
Michael J. Pienta, Pierre-Emmanuel Noly, Allison M. Janda, Paul C. Tang, Abbas Bitar, Michael R. Mathis, Keith D. Aaronson, Francis D. Pagani, Donald S. Likosky, Ashraf Shaaban Abdel Aziz Abou El Ela, Michael P. Thompson, Robert B. Hawkins, Peter Sassalos, Keith Aaronson, Supriya Shore, Thomas Cascino, Min Zhang, Jeffrey S. McCullough, Grace Chung, Michelle Hou, Tessa M.F. Watt, Alexander Brescia, Gardner L. Yost, James William Stewart, Austin Airhart, Daniel Liesman, and Khalil Nassar
- Subjects
Pulmonary and Respiratory Medicine ,Surgery ,Cardiology and Cardiovascular Medicine - Published
- 2023
- Full Text
- View/download PDF
4. Interhospital variability in health care–associated infections and payments after durable ventricular assist device implant among Medicare beneficiaries
- Author
-
Donald S. Likosky, Guangyu Yang, Min Zhang, Preeti N. Malani, Michael D. Fetters, Raymond J. Strobel, Carol E. Chenoweth, Hechuan Hou, Francis D. Pagani, Ashraf Shaaban Abdel Aziz Abou El Ela, Paul C. Tang, Michael P. Thompson, Keith Aaronson, Supriya Shore, Thomas Cascino, Katherine B. Salciccioli, Jeffrey S. McCullough, Michelle Hou, Allison M. Janda, Michael R. Mathis, Tessa M.F. Watt, Michael J. Pienta, Alexander Brescia, Austin Airhart, Daniel Liesman, and Khalil Nassar
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.medical_treatment ,media_common.quotation_subject ,Psychological intervention ,030204 cardiovascular system & hematology ,Medicare ,Health care associated ,Article ,Ventricular Function, Left ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Registries ,Aged ,Retrospective Studies ,media_common ,Heart Failure ,Cross Infection ,business.industry ,Incidence (epidemiology) ,Medicare beneficiary ,Payment ,Patient Discharge ,United States ,Confidence interval ,Treatment Outcome ,030228 respiratory system ,Ventricular assist device ,Emergency medicine ,Surgery ,Heart-Assist Devices ,Implant ,Health Expenditures ,Cardiology and Cardiovascular Medicine ,business - Abstract
OBJECTIVE: The objective of this study was to investigate variations across hospitals in infection rates and associated costs, the latter reflected in 90-day Medicare payments. Despite high rates and expenditures of healthcare-associated infections associated with durable ventricular assist device implant, few studies have examined inter-hospital variation and associated costs. METHODS: Clinical data on 8688 patients who received primary durable ventricular assist devices from July 2008 to July 2017 from The Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) hospitals (n=120) were merged with post-implant 90-day Medicare claims. Terciles of hospital-specific, risk-adjusted infection rates per 100 patient-months were estimated using Intermacs and associated with Medicare payments (among 5440 Medicare beneficiaries). Primary outcomes included infections within 90 days of implant and Medicare payments. RESULTS: There were 3982 infections identified among 27.8% (2,417/8,688) of patients developing an infection. The median (25(th), 75(th) percentile) adjusted incidence of infections (per 100 patient-months) across hospitals was 14.3 (9.3, 19.5) and varied by hospital (range 0.0 – 35.6). Total Medicare payments from implant to 90-days were 9.0% (absolute difference: $13,652) greater in high versus low infection tercile hospitals, p
- Published
- 2022
- Full Text
- View/download PDF
5. Failure to rescue: A candidate quality metric for durable left ventricular assist device implantation
- Author
-
Michael J. Pienta, Thomas M. Cascino, Donald S. Likosky, Amir A. Ghaferi, Keith D. Aaronson, Francis D. Pagani, Michael P. Thompson, Ashraf Shaaban Abdel Aziz Abou El Ela, Paul C. Tang, Keith Aaronson, Supriya Shore, Thomas Cascino, Katherine B. Salciccioli, Min Zhang, Jeffrey S. McCullough, Michelle Hou, Allison M. Janda, Michael R. Mathis, Tessa M.F. Watt, Alexander Brescia, Austin Airhart, Daniel Liesman, and Khalil Nassar
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Failure to rescue ,business.industry ,Mortality rate ,medicine.medical_treatment ,media_common.quotation_subject ,Prom ,Logistic regression ,Ventricular assist device ,Emergency medicine ,medicine ,Surgery ,Quality (business) ,Metric (unit) ,Cardiology and Cardiovascular Medicine ,Complication ,business ,media_common - Abstract
Failure to rescue (FTR), defined as death after a complication, is recognized as a principal driver of variation in mortality among hospitals. We evaluated FTR as a quality metric in patients who received durable left ventricular assist devices (LVADs) using the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support.Data on 13,617 patients who received primary durable LVADs from April 2012 to October 2017 at 131 hospitals that performed at least 20 implants were analyzed from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support. Rates of major complications and FTR were compared across risk-adjusted in-hospital mortality terciles (low, medium, high) and hospital volume. Logistic regression was used to estimate expected FTR rates on the basis of patient factors for each major complication.The overall unadjusted in-hospital mortality rate was 6.96%. Risk-adjusted in-hospital mortality rates varied 3.1-fold across terciles (low, 3.3%; high, 10.3%; P trend.001). Rates of major complications varied 1.1-fold (low, 34.0%; high, 38.8%; P .0001). Among patients with a major complication, 854 died in-hospital for an FTR rate of 17.7%, with 2.8-fold variation across mortality terciles (low, 8.5%; high, 23.9%; P .0001). FTR rates were highest for renal dysfunction requiring dialysis (45.3%) and stroke (36.5%). Higher average annual LVAD volume was associated with higher rates of major complications (10 per year, 26.7%; 10-20 per year, 34.0%; 20-30 per year, 34.0%;30 per year, 40.1%; P trend.0001) whereas hospitals implanting10 per year had the highest FTR rate (10 per year, 23.5%; 10-20 per year, 16.5%; 20-30 per year, 17.0%;30 per year, 17.9%; P = .03).FTR might serve as an important quality metric for durable LVAD implant procedures, and identifying strategies for successful rescue after complications might reduce hospital variations in mortality.
- Published
- 2023
- Full Text
- View/download PDF
6. Emergency cesarean section in pregnant trauma patients presenting after motor vehicle collision
- Author
-
Michelle Hough, Jeffry Nahmias, Jeffrey Santos, Lourdes Swentek, Robert Bristow, Jennifer Butler, and Areg Grigorian
- Subjects
Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Background: Most pregnant trauma patients (PTPs) present after motor vehicle collision (MVC). The national rate and risk factors for emergency cesarean section (ECS) during the index hospitalization for pregnant trauma patients (PTPs) are unknown. We sought to investigate the national rate of ECS in PTPs presenting after MVC, hypothesizing a higher risk of ECS among those with severe injuries or elevated shock index (SI). Methods: The 2020–2021 TQIP was queried for PTPs presenting after MVC. PTPs that underwent ECS were compared to patients that did not undergo ECS. Elevated SI was defined as ≥1. Severe injury was defined by abbreviated injury scale grade ≥3. Bivariate and multivariable logistic regression analyses were performed. Results: From 1183 PTPs, 95 (8.0 %) underwent ECS. The median time to ECS was 115 min. The ECS group had higher rates of lung (27.4 % vs. 12.2 %, p
- Published
- 2024
- Full Text
- View/download PDF
7. Archaeology, climate change and human adaptation in southern Africa: Evidence from Mapela and Little Mapela, southern Africa
- Author
-
Shadreck Chirikure, Foreman Bandama, Michelle House, Munyaradzi Manyanga, and Robert T. Nyamushosho
- Subjects
African cosmologies ,Adaptation ,Resilience ,Historical ecology ,Southern africa ,Geography. Anthropology. Recreation ,Archaeology ,CC1-960 - Abstract
In Africa south of the Zambezi River, archaeologists and other experts have long explored the impact of climate and environmental changes to the development of ancient civilizations during the Iron Age (CE 200–1900). Some of the prevailing thought is however still rooted in environmental deterministic models informed by selected ethnographies, stable isotopes and archaeological evidence. For instance, the drought brought by the medieval Little Ice Age is assumed to have collapsed the civilisation at Mapungubwe in the Shashi-Limpopo valley around 1300 CE. And yet, within the wider region, and in similar ecological settings, upstream (Shashi and Upper Limpopo) and downstream civilisations (Lower Limpopo), persisted and thrived through the same climatic challenges. We draw on African cosmologies, resilience theory and archaeological evidence from Mapela and Little Mapela to spotlight adaptation strategies utilised by their inhabitants to build resilience through time. The main conclusion is that even in cases of climatic extremes, humans responded to opportunities and constraints in context specific ways.
- Published
- 2024
- Full Text
- View/download PDF
8. The impact of Middle Eastern Origin, HIV, HCV, and HIV/HCV co-infection in the development of hypovitaminosis D in adults
- Author
-
Aven Sidhu, Saad Warraich, Osamah Alenezi, and Michelle Hou
- Subjects
Adult ,Male ,0301 basic medicine ,Hepatitis C Virus ,medicine.medical_specialty ,Hepatitis C virus ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,Middle East ,03 medical and health sciences ,0302 clinical medicine ,Hypovitaminosis ,Internal medicine ,adults ,Genetics ,Vitamin D and neurology ,Humans ,Medicine ,Statistical analysis ,030212 general & internal medicine ,Molecular Biology ,Genetics (clinical) ,Coinfection ,business.industry ,Racial Groups ,virus diseases ,Retrospective cohort study ,Original Articles ,Vitamin D Deficiency ,Hepatitis C ,030112 virology ,3. Good health ,hypovitaminosis D ,Middle Eastern origin ,Original Article ,Female ,business ,Human Immunodeficiency Virus ,Co infection - Abstract
Background A relationship between hypovitaminosis D and infection with HIV and HCV has been established in the scientific literature. Studies comparing these illnesses to other risk factors for development of hypovitaminosis D, such as being of Middle Eastern origin, have been lacking. The goals of this study were: (a) to document vitamin D levels in groups of individuals at high risk of developing its deficiency, (b) analyze the data collected to numerically determine which group had the lowest average vitamin D levels, and (c) discuss the impact of the findings and offer possible explanations. Methods This retrospective observational study involved reviewing medical charts and documenting recent vitamin D levels. Our subgroups were: (a) individuals infected with HIV, (b) individuals infected with HCV, (c) individuals co‐infected with HIV/HCV, and (d) people of Middle Eastern origin. The gathered data was subsequently subjected to statistical analysis. Results People of Middle Eastern origin were found more likely to be vitamin D deficient as compared to those infected with HIV, HCV, or co‐infected with both HIV and HCV. Conclusion This suggests that genetic and environmental factors unique to otherwise healthy Middle Eastern people are more detrimental, in terms of developing hypovitaminosis D, than being chronically infected with the aforementioned illnesses.
- Published
- 2018
- Full Text
- View/download PDF
9. Urea-based amino sugar agent clears murine liver and preserves protein fluorescence and lipophilic dyes
- Author
-
Michelle Hough, Michael Fenlon, Alison Glazier, Celia Short, Gerardo Esteban Fernandez, Jiabo Xu, Elaa Mahdi, Kinji Asahina, and Kasper S Wang
- Subjects
3D imaging ,bile duct ligation ,computational imaging ,fluorescence microscopy ,lipophilic tracers ,liver clearing ,Biology (General) ,QH301-705.5 - Abstract
Five established clearing protocols were compared with a modified and simplified method to determine an optimal clearing reagent for three-dimensionally visualizing fluorophores in the murine liver, a challenging organ to clear. We report successful clearing of whole liver lobes by modification of an established protocol (UbasM) using only Ub-1, a urea-based amino sugar reagent, in a simpler protocol that requires only a 24-h processing time. With Ub-1 alone, we observed sufficiently preserved liver tissue structure in three dimensions along with excellent preservation of fluorophore emissions from endogenous protein reporters and lipophilic tracer dyes. This streamlined technique can be used for 3D cell lineage tracing and fluoroprobe-based reporter gene expression to compare various experimental conditions.
- Published
- 2021
- Full Text
- View/download PDF
10. Prominin‐1‐expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury
- Author
-
Michael Fenlon, Celia Short, Jiabo Xu, Nicolas Malkoff, Elaa Mahdi, Michelle Hough, Alison Glazier, Calvin Lee, Kinji Asahina, and Kasper S. Wang
- Subjects
Biliary atresia ,cell lineage tracing ,cholangiocyte ,cholestasis ,liver fibrosis ,RNA‐seq ,Physiology ,QP1-981 - Abstract
Abstract Cholestatic liver injury is associated with intrahepatic biliary fibrosis, which can progress to cirrhosis. Resident hepatic progenitor cells (HPCs) expressing Prominin‐1 (Prom1 or CD133) become activated and participate in the expansion of cholangiocytes known as the ductular reaction. Previously, we demonstrated that in biliary atresia, Prom1(+) HPCs are present within developing fibrosis and that null mutation of Prom1 significantly abrogates fibrogenesis. Here, we hypothesized that these activated Prom1‐expressing HPCs promote fibrogenesis in cholestatic liver injury. Using Prom1CreERT2‐nLacZ/+;Rosa26Lsl‐GFP/+ mice, we traced the fate of Prom1‐expressing HPCs in the growth of the neonatal and adult livers and in biliary fibrosis induced by bile duct ligation (BDL). Prom1‐expressing cell lineage labeling with Green Fluorescent Protein (GFP) on postnatal day 1 exhibited an expanded population as well as bipotent differentiation potential toward both hepatocytes and cholangiocytes at postnatal day 35. However, in the adult liver, they lost hepatocyte differentiation potential. Upon cholestatic liver injury, adult Prom1‐expressing HPCs gave rise to both PROM1(+) and PROM1(‐) cholangiocytes contributing to ductular reaction without hepatocyte or myofibroblast differentiation. RNA‐sequencing analysis of GFP(+) Prom1‐expressing HPC lineage revealed a persistent cholangiocyte phenotype and evidence of Transforming Growth Factor‐β pathway activation. When Prom1‐expressing cells were ablated with induced Diphtheria toxin in Prom1CreERT‐nLacZ/+;Rosa26DTA/+ mice, we observed a decrease in ductular reactions and biliary fibrosis typically present in BDL as well as decreased expression of numerous fibrogenic gene markers. Our data indicate that Prom1‐expressing HPCs promote biliary fibrosis associated with activation of myofibroblasts in cholestatic liver injury.
- Published
- 2020
- Full Text
- View/download PDF
11. Assessing anesthesiology residents’ out-of-the-operating-room (OOOR) emergent airway management
- Author
-
Lauryn R. Rochlen, Michelle Housey, Ian Gannon, Shannon Mitchell, Deborah M. Rooney, Alan R. Tait, and Milo Engoren
- Subjects
Urgent airway management ,Outside the OR intubations ,Anesthesiology ,RD78.3-87.3 - Abstract
Abstract Background At many academic institutions, anesthesiology residents are responsible for managing emergent intubations outside of the operating room (OOOR), with complications estimated to be as high as 39%. In order to create an OOOR training curriculum, we evaluated residents’ familiarity with the content and correct adherence to the American Society of Anesthesiologists’ Difficult Airway Algorithm (ASA DAA). Methods Residents completed a pre-simulation multiple-choice survey measuring their understanding and use of the DAA. Residents then managed an emergent, difficult OOOR intubation in the simulation center, where two trained reviewers assessed performance using checklists. Post-simulation, the residents completed a survey rating their behaviors during the simulation. The primary outcome was comprehension and adherence to the DAA as assessed by survey responses and behavior in the simulation. Results Sixty-three residents completed both surveys and the simulation. Post-survey responses indicated a shift toward decreased self-perceived familiarity with the DAA content compared to pre-survey responses. During the simulation, 22 (35%) residents were unsuccessful with intubation. Of these, 46% placed an LMA and 46% prepared for cricothyroidotomy. Nineteen residents did not attempt intubation. Of these, only 31% considered LMA placement, and 26% initiated cricothyroidotomy. Conclusions Many anesthesiology residency training programs permit resident autonomy in managing emergent intubations OOOR. Residents self-reported familiarity with the content of and adherence to the DAA was higher than that observed during the simulation. Curriculum focused on comprehension of the DAA, as well as improving communication with higher-level physicians and specialists, may improve outcomes during OOORs.
- Published
- 2017
- Full Text
- View/download PDF
12. Pure erythroid leukemia
- Author
-
Méghan Forest, Simon F. Roy, Michelle Houde, and Antonio Maietta
- Subjects
AML ,bone marrow pathology ,hematological oncology ,pancytopenia ,pure erythroid leukemia ,Medicine ,Medicine (General) ,R5-920 - Abstract
Abstract Pure erythroid leukemia is a rare and aggressive form of acute leukemia with a deleterious clinical course. It is of erythroid lineage without myeloblastic component, representing >80% of marrow cellularity, with ≥30% proerythroblasts.
- Published
- 2020
- Full Text
- View/download PDF
13. Immunohistochemistry for myc predicts survival in colorectal cancer.
- Author
-
Christopher W Toon, Angela Chou, Adele Clarkson, Keshani DeSilva, Michelle Houang, Joseph C Y Chan, Loretta L Sioson, Lucy Jankova, and Anthony J Gill
- Subjects
Medicine ,Science - Abstract
MYC over-expression as determined by molecular means has been reported as a favorable prognostic biomarker in colorectal carcinoma (CRC). However MYC expression analysis is not available in the routine clinical setting. We investigated whether immunohistochemistry (IHC) for the myc protein using a novel commercially available rabbit monoclonal antibody [clone Y69] which is currently in widespread clinical use for lymphoma diagnosis could be used to predict outcome in resected CRC. Myc IHC was performed on a tissue microarray (TMA) comprising a retrospective cohort of 1421 CRC patients and scored blinded as to all clinical and pathological data. IHC was also performed on a subcohort of whole section CRCs to assess staining characteristics and concordance with TMA expression. MYC over-expression was found in 980 (69%) of CRCs and was associated with tumor stage and DNA mismatch repair/BRAF status. There was substantial agreement between TMA and whole section myc IHC (kappa = 0.742, p
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.